BioGenerator is the investment arm of BioSTL.

BioGenerator produces a sustained pipeline of successful bioscience companies and entrepreneurs in St. Louis by creating, growing and investing in biotech startups.

BioGenerator is a nonprofit subsidiary of BioSTL, which advances St. Louis’ prosperity by cultivating a thriving bioscience sector, building regional capacity to capitalize on St. Louis’ world-class medical and plant biosciences.

For more information, visit BioGenerator or follow their updates on:

Locations

    Industries

      Financials

      • 24

      BioGenerator Articles

      Mighty Cricket Awarded $650,000 USDA Grant to Transform Food Waste into Cricket Feed

      Shared Services in the St. Louis AgTech and BioTech Innovation Districts

      Big Pharma Teams Up with St. Louis Immunotherapy Startup & Why it Matters

      St. Louis Manufacturing: Tradition and New Direction

      STL AgTech Ecosystem Partners to Offer 5 Arch Grants to AgriFoodTech Startups

      St. Louis Startup Scene: Balto Opens Office, Brain-Computer Interface Cleared to Sell

      Insect Control AgTech Startup Raises $1M

      Canopy Biosciences Acquired by Bruker After 4 Years As BioGenerator Incubated Startup

      In 2019, BioGenerator Invested $3.2 Million in 16 Bioscience Companies in St. Louis

      BioGenerator’s New Strategies Address St. Louis’ Talent Shortage

      NYC Company Healthy Bytes Raises $1.25M to Relocate to St. Louis

      Phas3 Wins Paid Pilot at Colorado Hospitals

      Readout Health Produces New Medical Device to Easily Track Nutritional Ketosis

      BioGenerator Wins $750,000 in Federal Funds to Expand Labs and Grants to Build New St. Louis AgTech Companies

      Cortex Expands with Re-invention of Historic 4340 Duncan Building

      VaxNewMo’s Vaccine Breakthrough Published in Nature

      Galera Therapeutics Raises $150 Million to Advance “Breakthrough Therapy” for Debilitating Cancer Side Effect

      A “No” from Arch Grants Isn’t a “No” to Your Business

      BioGenerator and Kingdom Capital Lead $2.4 Million Series A Round in Canopy BioSciences

      BioGenerator

      Local Immunotherapy Startup Attracts $3 Million Investment

      SentiAR Scored A Major Milestone In Federal Grant Peer Review Process

      SentiAR

      SentiAR Awarded $2.2 Million Federal Grant to Advance Augmented Reality Device for Cardiologists

      St Louis Startup Boom Was 20 Years In The Making

      BioGenerator

      BioGenerator Wins $300K Federal Grant to Build Bioscience Companies In St. Louis

      AgIdea

      Biotech Crop Startup Plastomics Raises Investment For Early Seed Round

      St Louis Bioscience Startup Acquired at $100 Million Valuation

      The Agile Mission of BioGenerator’s Grants Program

      BioSTL Fundamentals

      How BioSTL Fundamentals is Elevating Early-Stage Entrepreneurs

      Dollar sign fundraising

      12 Fundraising Tips for BioTech Companies from Cultivation Capital’s Life Sciences Fund

      Dr. Juan Arhancet, Apse

      Why BioGenerator Works

      BioGenerator

      Cultivation Capital’s Life Sciences Fund Finds Sweet Spot

      St. Louis Startup Accelerator Guide

      Cultivation Capital Leads $1.2M Financing Round in S4

      Founder Series: Joseph Monahan of Confluence

      BioGenerator Lab

      Breaking Down BioGenerator

      BioGenerator Company Accuronix Targets Pancreatic Cancer

      STL Startup Funding

      STL Startup Funding Guide

      Bio STL Global STL EQ

      International Affair

      Disrupting Infection with Nanotechnology and Tom Cohen

      St. Louis Cited As An Example of “The Right Way to Build a Tech City.”

      Why All Wine Drinkers Will Love StiQit

      Can St. Louis Become the Next Bioscience Hub?

      From NY To STL: Why This Life-Science Company Relocated To The Midwest

      BioGenerator Gets International Nod, Arch Angels Flying High, Appistry’s Samson vs Goliath Legal Battle

      GirlsAskGuys Raises $1,000,000

      Founder of Kypha Awarded 2013’s St. Louis Entrepreneur of the Year

      Two St. Louis Venture Capital Firms Make Forbes ‘Big Money Midwest’ List